Meconium-stained amniotic fluid and hypoglycemia among term newborn infants

Ayala Maayan-Metzger*, Leah Leibovitch, Irit Schushan-Eisen, Tzipora Strauss, Jacob Kuint

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review


To evaluate whether meconium-stained amniotic fluid (MSAF) is a risk factor for neonatal hypoglycemia. Retrospective recording of medical charts of full-term infants born following observation of meconium-stained amniotic fluid to examine glucose levels in the first hours of life. Out of 803 infants of the study group, 68 (8.5) had glucose levels lower than 47 mg/dl. Most (6.7) had mild hypoglycemia, and 14 (1.8) had moderate or severe hypoglycemia (1.4 and 0.4 respectively). No infant developed clinical signs clearly related to hypoglycemia. Low-risk infants born following meconium-stained amniotic fluid are not at increased risk for neonatal hypoglycemia.

Original languageEnglish
Pages (from-to)283-287
Number of pages5
JournalFetal and Pediatric Pathology
Issue number5
StatePublished - Oct 2012
Externally publishedYes


  • Hypoglycemia
  • Meconium-stained amniotic fluid (MSAF)
  • Newborn


Dive into the research topics of 'Meconium-stained amniotic fluid and hypoglycemia among term newborn infants'. Together they form a unique fingerprint.

Cite this